IRCT20181124041746N1RecruitingPhase 2
Assesment and compair the prognosis of warfarin and rivaroxaban in patient with open heart surgery and endarterectomy
Trial Snapshot
- Phase
- Phase 2
- Status
- Recruiting
- Enrollment
- 120
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 20 years to 70 years (—)
- Sex
- All
Inclusion Criteria
- •Patients undergoing CABG and endarterectomy
Exclusion Criteria
- •Patients with prosthetic valve
- •ESRD patents
Investigators
Similar Trials
Not yet recruiting
Not Applicable
Comparison of Efficacy and Safety between Warfarin, Rivaroxaban and Edoxaban in patients with acute pulmonary embolism in showa universityJPRN-UMIN000020069Division of Cardiology, Department of Medicine,Showa university100
Recruiting
Phase 4
Outcomes of Warfarin and Rivaroxaban (Xalerban) consumption in patients with Atrial fibrillatioIRCT20170530034232N2Vice-Chancellor For Research and Technology of Guilan University of Medical Sciences330
Withdrawn
Phase 4
A Prospective Study on Warfarin Management Post Heart Valve Replacement or Heart Valve Repair SurgeryPost Mechanical Heart Valve SurgeryWarfarin Management in post mechanical heart valve surgery patients.Cardiovascular - Other cardiovascular diseasesSurgery - Other surgeryACTRN12613000818730Flinders Medical Centre140
Active, not recruiting
Phase 3
The efficacy of different warfarin starting doses (3 mg versus 5 mg) and the corresponding dosing schedule in patients diagnosed with deep vein thrombosisThe efficacy of different warfarin initiating dose in patients diagnosed with venous thromboembolismwarfarin,initiating dose,efficacy,venous thromboembolismTCTR20180328002Faculty of Medicine Siriraj Hospital, Mahidol University56
Completed
Phase 2
The effects of Warfarin on permacath functioIRCT20200516047461N1Esfahan University of Medical Sciences86